April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Retinal Ganglion Cell Layer Thinning and Vision Outcome in NAION and Optic Neuritis over Six Months
Author Affiliations & Notes
  • Jui-Kai Wang
    Department of Electrical and Computer Engineering, The University of Iowa, Iowa City, IA
  • Mark J Kupersmith
    Department of Neuro-Ophthalmology, Roosevelt Hospital and NYEE, New York, NY
  • Mona K Garvin
    Department of Electrical and Computer Engineering, The University of Iowa, Iowa City, IA
    VA Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA
  • Randy H Kardon
    VA Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA
    Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA
  • Footnotes
    Commercial Relationships Jui-Kai Wang, None; Mark Kupersmith, None; Mona Garvin, The University of Iowa (P); Randy Kardon, Acorda (C), Department of Veterans Affairs Research Foundation, Iowa City, IA (S), Fight for Sight Inc (S), Novartis (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5780. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jui-Kai Wang, Mark J Kupersmith, Mona K Garvin, Randy H Kardon; Retinal Ganglion Cell Layer Thinning and Vision Outcome in NAION and Optic Neuritis over Six Months. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5780.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

We previously showed that retina ganglion cell layer (GCL) thinning occurs within one month of acute optic neuritis (ON) and non-arteritic anterior ischemic optic neuropathy (NAION), long before retinal nerve fiber layer (RNFL) thinning or complete loss of acute swelling are seen (ARVO 2013). Here we investigate the trajectory of GCL thinning over 6 months in both disorders in order to determine when most of the loss occurs and how the amount of GCL loss relates to the visual outcome.

 
Methods
 

Using spectral domain optical coherence tomography (SD-OCT, Cirrus 4000) of the optic nerve head and macula areas, we prospectively evaluated 29 eyes (age 36±10) with new onset ON and 29 eyes (age 65±12) with NAION within 2 weeks of vision loss (acute stage), at one month and at 6 months. We used 3D-segmentation to calculate the GCL plus inner plexiform layer thickness for each macula image.

 
Results
 

The maximum amount of GCL thinning occurred at 1 month with mean loss of 19.62 µm ± 12.62 for NAION and 8.68 µm ± 5.09 for ON eyes. A modest, further thinning of the GCL occurred between 3 and 6 months in NAION (6.11 µm and 1.11 µm, respectively) and in ON (2.61 µm and 0.62 µm, respectively). The amount of GCL thinning at 1 month strongly correlated with the amount of GCL loss at 6 months in NAION (r=0.854) and in ON (r=0.838) eyes. There was also a significant correlation between the GCL thickness at one month and the mean deviation of the visual field for NAION eyes (r= 0.507) but not in ON eyes (r=0.052). The RNFL was thickened, particularly in NAION eyes, at presentation and 1 month and did not correlate with mean deviation of the visual field in either NAION or ON at that time point. The RNFL did not show thinning until the 3 and 6-month time points.

 
Conclusions
 

For acute ON and NAION, the largest proportion of GCL loss has already occurred at one month (in contrast to the RNFL, due to continued swelling) and suggests that neural preservation or protection therapy must be delivered earlier than one month to significantly prevent loss of retinal ganglion cells in both disorders.

     
Keywords: 531 ganglion cells • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound)  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×